Larvol Delta - Centessa-Pharmaceuticals-Announces-Positive-Topline-Data-from-ProofofConcept-Study-of-SerpinPC-in-Severe-Hemophilia-A-and-B-Patients-Not-on-Prophylaxis

SerpinPC (APC-specific serpin) - Centessa

https://www.globenewswire.com/news-release/2021/09/09/2294194/0/en/Centessa-Pharmaceuticals-Announces-Positive-Topline-Data-from-Proof-of-Concept-Study-of-SerpinPC-in-Severe-Hemophilia-A-and-B-Patients-Not-on-Prophylaxis.html

Sep 9, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next